Pan Asia Metals (“Pan Asia” or “the Company”) is a recent listing on the ASX, with a focus on developing “critical” metals projects in the emerging economic powerhouse of SE Asia.

Activities over the past 11 months have yielded very encouraging results for Great Southern Mining

We have assigned BNK a value of $1.12 per share. The valuation is based on a PE multiple of 10x the FY21 forecast EPS plus the current value of the net trailing commission receivable per share. This represents an upside of 72.3% on the share price of $0.65 at 4 September 2020.

PTX is a clinical stage oncology company with a focus on developing targeted and cellular cancer therapies. Targeted therapies are a focus for anticancer drug development, with the aim of personalising treatment based on a person’s genes and proteins to prevent, diagnose and treat the disease

Our base case valuation of Triangle Energy is A$0.14/sh per share. 50% of that value is driven by risked exploration upside. Our risk factor is 20%. The valuation ranges in the table below assume long term oil prices of A$55/bbl at the low end to A$95/bbl at the high end. Given historical oil prices, this is not an aggressive price range.